TEV-48125
Teva lifted by positive migraine drug results
May 15, 2015Sales and Marketing TEV-48125, Teva, headaches, migraine
Patients who take either dose of Teva’s investigational treatment for chronic migraine improve more than those taking a placebo according …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
